Occudo Quantitative Strategies LP Kempharm, Inc Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	N/A	6,404 Added 39.5%	22,615 $111,000
Q2 2023 Aug 14, 2023	SELL	$4.94 - $6.29 $8,699 - $11,076	-1,761 Reduced 9.8%	16,211 $80,000
Q1 2023 May 15, 2023	BUY	$4.13 - $6.27 $18,407 - $27,945	4,457 Added 32.98%	17,972 $98,000
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $56,843 - $77,539	-13,797 Reduced 50.52%	13,515 $62,000
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $67,662 - $102,996	-15,036 Reduced 35.51%	27,312 $170,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $66,884 - $86,683	-16,638 Reduced 28.21%	42,348 $189,000
Q1 2022 May 16, 2022	BUY	$5.0 - $9.26 $294,930 - $546,210	58,986 New	58,986 $297,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.